Rocket Pharmaceuticals (NASDAQ:RCKT) Issues Earnings Results, Misses Estimates By $0.02 EPS
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report) announced its quarterly earnings data on Monday. The biotechnology company reported ($0.74) EPS for the quarter, missing analysts’ consensus estimates of ($0.72) by ($0.02), Briefing.com reports. During the same quarter in the previous year, the firm earned ($0.82) EPS. Rocket Pharmaceuticals Price Performance NASDAQ:RCKT opened at $20.13 on […]
More Stories
Democratic Rep. Cherfilus-McCormick Resigns Ahead of Ethics Committee Sanctions Hearing
By Chase Smith Rep. Sheila Cherfilus-McCormick (D-Fla.) resigned from Congress on Tuesday, stepping down hours before the House Ethics Committee...
Is Hell’s Paradise Season 3 Renewed? Release Date, Plot, and Episodes
With the recent release of the anime series Hell’s Paradise, fans are curious to know about the renewal status of...
Who is Lana Condor? Movies and Controversy at the Fashion Trust Awards Show
From an orphanage to becoming a well-known face in the American film industry, Lana has come a long way. Want...
Bridgerton Season 5: Release Date, Cast, Teaser, and Recent Updates
Fans’ favourite series, Bridgerton season 5, is coming back soon. The series’ official network, Netflix, has officially announced the renewal....
CBP to Begin First Phase of Tariff Refunds Following Supreme Court Ruling
By Aldgra Fredly U.S. Customs and Border Protection (CBP) is set to begin the first phase of its refund process...
2 US Embassy Employees, 2 Mexican Officials Killed in Car Crash
By Aldgra Fredly Two instructor officers from the U.S. Embassy in Mexico and two Mexican officials died in a car...